CD7 and TCR were disrupted using the CRISPR/Cas9 system to prevent fratricides and GvHD, respectively, while C7R strongly promotes CAR-T cell expansion via the IL7Ra intracellular segment. This evidence concerns the gene CD7 and graft versus host disease.